93 related articles for article (PubMed ID: 2794297)
1. Immunoglobulin composition of three commercially available intravenous immunoglobulin preparations.
Herrera AM; Saunders NB; Baker JR
J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 1):556-61. PubMed ID: 2794297
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G subclass distribution in three human intravenous immunoglobulin preparations.
Burckhardt JJ; Gardi A; Oxelius VA; Preud'homme JL; Scherz R; Skvaril F; Heiniger HJ
Vox Sang; 1989; 57(1):10-4. PubMed ID: 2508324
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin subclass concentration in preterm infants treated prophylactically with different intravenous immunoglobins.
Amato M; Hüppi P; Imbach P; Llauto A; Bürgi W
Am J Perinatol; 1995 Sep; 12(5):306-9. PubMed ID: 8540928
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of IgG subclasses and their biological activity in bioglobulin].
Bucholc B; Banach W
Med Dosw Mikrobiol; 1998; 50(1-2):105-13. PubMed ID: 9857620
[TBL] [Abstract][Full Text] [Related]
6. Differences among available immunoglobulin preparations for intravenous use.
Skvaril F; Gardi A
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S43-8. PubMed ID: 2456510
[TBL] [Abstract][Full Text] [Related]
7. Opsonic and physicochemical characteristics of intravenous immunoglobulin preparations.
van Furth R; Braat AG; Leijh PC; Gardi A
Vox Sang; 1987; 53(2):70-5. PubMed ID: 3500539
[TBL] [Abstract][Full Text] [Related]
8. Different Gm allotype amounts in human intravenous immunoglobulin (IVIG) preparations; survival of foreign Gm allotypes in immunodeficient patients.
Oxelius VA; Eibl MM
Clin Exp Immunol; 1996 Nov; 106(2):203-7. PubMed ID: 8918564
[TBL] [Abstract][Full Text] [Related]
9. [IgG subclass distribution in intravenous immunoglobulin products: determination of reproducibility of a method of IgG subclass determination. Ring Study of the "Plasma Blood Components" Section of the German Society of Transfusion Medicine and Immunohematology].
Kotitschke R; Lang H; Page M
Infusionsther Transfusionsmed; 1995 Dec; 22(6):360-3. PubMed ID: 8589597
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of various intravenous immunoglobulin preparations.
Lundblad JL; Londeree N; Mitra G
J Infect; 1987 Jul; 15 Suppl 1():3-12. PubMed ID: 2822815
[TBL] [Abstract][Full Text] [Related]
11. Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products.
Diemel RV; ter Hart HG; Derksen GJ; Koenderman AH; Aalberse RC
Transfusion; 2005 Oct; 45(10):1601-9. PubMed ID: 16181211
[TBL] [Abstract][Full Text] [Related]
12. The effect of processing methods on intravenous immune globulin preparations.
Lundblad JL; Londeree N
J Hosp Infect; 1988 Aug; 12 Suppl D():3-15. PubMed ID: 2902127
[TBL] [Abstract][Full Text] [Related]
13. Determination of the molecular size distribution of immunoglobulin G (IgG) in intravenous IgG-albumin formulations by high-performance liquid chromatography.
Lee JK; Deluccia FJ; Kelly EL; Davidson C; Borger FR
J Chromatogr; 1988 Jul; 444():141-52. PubMed ID: 3204129
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G (IgG) and IgG subclass reference intervals in children, using Optilite® reagents.
Grunewald O; Lopez B; Brabant S; Rogeau S; Deschildre A; Phrommavanh V; Lefort M; Moitrot E; Gyselinckx D; Deleplancque AS; Lefevre G; Labalette M; Dubucquoi S
Clin Chem Lab Med; 2018 Jul; 56(8):1319-1327. PubMed ID: 29630506
[TBL] [Abstract][Full Text] [Related]
15. Distribution of human IgG subclasses in commercial intravenous immunoglobulin preparations. A rate nephelometric method.
Beck OE; Kaiser PE
Vox Sang; 1981; 41(2):79-84. PubMed ID: 7331283
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
[TBL] [Abstract][Full Text] [Related]
17. Significant, quantifiable differences exist between IgG subclass standards WHO67/97 and ERM-DA470k and can result in different interpretation of results.
Wilson C; Ebling R; Henig C; Adler T; Nicolaevski R; Barak M; Cazabon J; Maisin D; Lepoutre T; Gruson D; Hughes RG; Parker AR
Clin Biochem; 2013 Nov; 46(16-17):1751-5. PubMed ID: 23891780
[TBL] [Abstract][Full Text] [Related]
18. Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations.
Maranich AM; Rajnik M
Pediatrics; 2009 Sep; 124(3):e484-8. PubMed ID: 19706589
[TBL] [Abstract][Full Text] [Related]
19. IgG subclass determination in human sera with commercially available reagents: comparison of different assay systems.
Leibl H; Mannhalter JW; Eibl MM
Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):85-93. PubMed ID: 1581414
[TBL] [Abstract][Full Text] [Related]
20. IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.
Hammarström L; Granström M; Oxelius V; Persson MA; Smith CI
Clin Exp Immunol; 1984 Mar; 55(3):593-601. PubMed ID: 6705269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
